Remedium Lifecare
Close ·
- P/E
- 2.60
Key Fundamentals
MicrocapCommercial ServicesServicesPrice-based figures at the close · TTM
- ROCE
- —
- Debt to Equity
- 10.36
- EPS (TTM)
- ₹0.10
- Book Value
- ₹1.04
- Market Cap
- —
- P/E (TTM)
- 2.60
- P/B
- 0.25
- ROE
- 4.85%
- Dividend Yield
- 0.00%
- EBITDA
- ₹9.70 Cr
- 52W High
- ₹1.60
- 52W Low
- ₹0.23
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 85/100
Category scores
- Quality
- 14
- Poor
- Returns, margins, earnings quality 24% weight
- Valuation
- 52
- Average
- Cheap vs sector & own history 26% weight
- Financial Health
- 43
- Weak
- Solvency, leverage, coverage 10% weight
- Momentum
- 7
- Poor
- Trend strength, vol-adjusted 13% weight
- Ownership
- 66
- Strong
- FII/DII/promoter flows 26% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 0.21 times its book value
Weaknesses
4- Company has low interest coverage ratio.
- Promoter holding is low: 1.13%
- Earnings include an other income of Rs.10.8 Cr.
- Company has high debtors of 695 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 4 | 7 |
| Oscillators | Bullish | 2 | 4 | 3 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bullish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 54.03
- Neutral
- MACD (12,26,9)
- 0.00
- Bullish
- SMA (50)
- 0.26
- Bearish
- SMA (200)
- 0.46
- Bearish
As of
Growth Rate
Annual windows: Fewer than two fiscal years are reported, so there is no annual growth yet.
Trailing twelve months: The latest quarterly results are more than a year old.
Quarterly Results
₹ CrResults for the period ended Dec 2025 were due by 14 Feb 2026 and are not in this table yet.
| Particulars | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|
| Sales | 264 | 113 | 111 |
| Expenses | 265 | 112 | 104 |
| Operating Profit | −0.46 | 1.87 | 7.38 |
| OPM % | −0.17% | 1.65% | 6.65% |
| Other Income | 0.66 | 3.48 | 3.25 |
| Interest | 1.59 | −0.36 | 0.19 |
| Depreciation | 0.01 | 0 | 0 |
| PBT | −1.4 | 5.71 | 10.44 |
| Tax % | 45.71% | 18.56% | 17.34% |
| Net Profit | −2.05 | 4.65 | 8.62 |
| EPS (₹) | −0.02 | 0.05 | 0.1 |
Profit & Loss
₹ Cr| Particulars | Mar 2025 |
|---|---|
| Sales | 405 |
| Expenses | 404 |
| Operating Profit | 1 |
| OPM % | 0.3% |
| Other Income | 11 |
| Interest | 8 |
| Depreciation | 0 |
| PBT | 4 |
| Tax % | 51% |
| Net Profit | 2 |
| EPS (₹) | 0.02 |
| Div. Payout % | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2025 | Sep 2025 |
|---|---|---|
| Equity Capital | 40 | 88 |
| Reserves | 4 | 17 |
| Borrowings | 1,141 | 1,088 |
| Other Liabilities | 535 | 430 |
| Total Liabilities | 1,720 | 1,623 |
| Fixed Assets | 0 | 6 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 1,720 | 1,617 |
| Total Assets | 1,720 | 1,623 |
Cash Flow
₹ Cr| Particulars | Mar 2025 |
|---|---|
| Operating | −1,135 |
| Investing | 0 |
| Financing | 1,136 |
| Net Cash Flow | 1 |
| Free Cash Flow | −1,135 |
| CFO/OP | −90,064 |
Ratios
| Particulars | Mar 2025 |
|---|---|
| Debtor Days | 695 |
| Inventory Days | 247 |
| Days Payable | 459 |
| Cash Conversion Cycle | 483 |
| Working Capital Days | 38 |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Remedium Lifecare insights
58 extracted metrics across FY11–FY26.
Documents
- 4 Aug 2025
Frequently Asked Questions about Remedium Lifecare
What does Remedium Lifecare Ltd do?
Where is Remedium Lifecare Ltd (SUPHA) listed?
Which sector does Remedium Lifecare Ltd belong to?
What is the PE ratio of Remedium Lifecare Ltd?
What is the 52-week high and low of Remedium Lifecare Ltd?
What is the Return on Equity (ROE) of Remedium Lifecare Ltd?
Company Information
Supha Pharmachem Ltd, formerly Remedium Lifecare, is a pharmaceutical supply-chain trader of APIs, advanced intermediates, KSMs/CRMs and other pharma chemicals for domestic and export markets. It operates through the Indian parent and Singapore subsidiary Remlife Global Pte Ltd and entered CIRP on March 17, 2026.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539561.md for Remedium Lifecare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.